Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine

Biochemical Pharmacology

Volumn 53, Issue 11, 1997, Pages 1725-1733

  Berkovic, Dinko ^a   Lüders, Sigrid ^b   Goeckenjan, Maren ^b   Hiddemann, Wolfgang ^b   Fleer, Eduard A M ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NONE

Author keywords

Cytotoxicity; Differenti ation; Etherlysophospholipids; Hexadecylphosphocholine; phospholipase A2; Signal transduction

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPID DERIVATIVE;

ACYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MATURATION; CELL STIMULATION; ENDOCYTOSIS; ENZYME INHIBITION; ENZYME REGULATION; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACYLATION; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; DRUG RESISTANCE; ENZYME ACTIVATION; HUMANS; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PHOSPHORYLCHOLINE; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0342547155     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00095-6     Document Type: Article

References (48)

1. Fleer AM, Kim DJ, Nagel GA, Eibl H, Unger C, Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie 13: 295-300, 1990.
2. Unger C, Alkylphosphocholine und Analoga. Entwicklung einer neuen Substanzgruppe mit antineoplastischer Wirkung. Thieme, Stuttgart 1-106, 1989.
3. Hilgard P, Stekar J, Voegeli R, Engel J, Schumacher W, Eibl H, Unger C, Berger MR, Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Clin Oncol 24: 1457-1467, 1988.
4. Unger C, Damenz W, Fleer EAM, Kim DJ, Breiser A, Hilgard P, Engel J, Nagel GA, Eibl H, Hexadecylphosphocholine, a new etherlipid analogue: Studies on the antineoplastic activity in vitro and in two. Acta Oncol 28: 213-217, 1989.
5. Scherf HR, Schuler B, Berger MR, Schmäl D, Therapeutic activity of hexadecylphosphocholine against mammary tumors in BD-VI rats. Lipids 22: 927-929, 1987.
6. Eibl H, Unger C, Hexadecylphosphocholine: A new selective antitumor drug. Cancer Treatment Rev 17: 233-242, 1990.
7. Hilgard P, Harleman JH, Voegeli R, Maurer HR, Echarti C, Unger C, The antineoplastic activity of hexadecylphosphocholine is associated with tumor cell differentiation. Proc Am Assoc Cancer Res 30: 3210, 1989.
8. Hochhuth C, Berkovic D, Eibl H, Unger C, Doenecke D, Effects of neoplastic phospholipids on parameters of cell differentiation in U 937 cells. J Cancer Res Clin Oncol 116: 459-466, 1990.
9. Schallier DC, Bruyneel EA, Storme GA, Hilgard P, Mareel MM, Antiinvasive activity of hexadecylphosphocholine in vitro. Anticancer Res 11: 1285-1292, 1991.
10. Zheng B, Oishi K, Shoji M, Eibl H, Berdel WE, Hajdu J, Vogler WR, Kuo JF, Inhibition of protein kinase C (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res 50: 3025-3031, 1990.
11. 3 and BM 41.440. Biochem Biophys Res Commun 157: 1000-1006, 1988.
12. Shoji M, Raynor RL, Berdel WE, Vogler WR, Kuo JF, Effects of thioether phospholipid BM 41-440 on protein kinase C and phorbol ester-induced differentiation on human leukemia HL 60 and KG-1 cells. Cancer Res 48: 6669-6673, 1988.
13. Kramer IM, van der Bend RL, Tool ATJ, van Blitterswijk WJ, Roos D, Verhoeven AJ, 1-O-hexadecyl-2-O-methylglycerol, a novel inhibitor of protein kinase C, inhibits respiratory burst in human neutrophils. J Biol Chem 264: 5876-5884, 1989.
14. Shoji M, Raynor RL, Fleer EAM, Eibl H, Vogler WR, Kuo JF, Effects of hexadecyl-phosphocholine on protein kinase C and TPA-induced differentiation of HL 60 cells. Lipids 26: 145-149, 1991.
15. Herrmann DBJ, Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues. J Natl Cancer Inst 75: 219-222, 1985.
16. Vogler WR, Whigham E, Bennett WD, Olson AC, Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines. Exp Hematol 13: 629-633, 1985.
17. Modollel M, Andreesen R, Pahlke W, Brugger U, Munder PG, Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkyllysophospholipids. Cancer Res 39: 4681-4686, 1985.
18. Berkovic D, Grunwald U, Menzel W, Unger C, Hiddemann W, Fleer EAM, Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. Eur J Cancer 31A: 2080-2085, 1995.
19. Geilen CC, Wieder T, Reutter W, Hexadecylphosphocholine inhibits translation of CTP: Cholinephosphate-cytidylyl-transferase in Madin-Darby canine kidney cells. J Biol Chew. 267: 6719-6724, 1992.
20. Salari H, Dryden P, Davenport R, Howard S, Jones K, Bittman R, Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells. Biochim Biophys Acta 1134: 81-88, 1992.
21. Berkovic D, Berkovic K, Fleer EAM, Eibl H, Unger C, Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL 60 and K 562 cell lines. Eur J Cancer 30A: 509-515, 1994.
22. Heesbeen EC, Verdonck LF, Staal GEJ, Rijksen G, Protein kinase C is not involved in the cytotoxic action of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine in HL 60 and K 562 cells. Biochem Pharmacol 47: 1481-1488, 1994.
23. Lu X, Arthur G, The differential susceptibility of A 427 and A 549 cell lines to the growth inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyllysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res 52: 2813-2817, 1992.
24. Lu X, Arthur G, Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF 7 and T 84 cell lines. Cancer Res 52: 2806-2812, 1992.
25. 2+ signalling by antitumor ether lipid analogues. Cancer Res 50: 4458-4463, 1990.
26. Powis G, Seewald MJ, Gratas C, Milder DC, Riebow J, Modest EJ, Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52: 2835-2840, 1992.
27. Überall F, Oberhuber H, Maly K, Zaknun J, Demuth L, Grunicke HH, Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 51: 807-812, 1991.
28. Bergren MI, Gallegos A, Dressier LA, Modest EJ, Powis G, Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 53: 4297-4302, 1993.
29. Bligh EG, Dyer WJ, A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
30. Pawelczyk T, Lowenstein JM, Inhibition of phospholipase CS by hexadecylphosphocholine and lysophospholipids with antitumor activity. Biochem Pharmacol 45: 493-497, 1993.
31. Fleer EAM, Berkovic D, Eibl H, Unger C, Investigations on the cellular uptake of hexadecylphosphocholine. Lipids 28: 731-736, 1993.
32. Vallari DS, Smith ZL, Snyder F, HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form. Biochem Biophys Res Commun 156: 1-8, 1988.
33. Schütze S, Berkovic D, Tomsing O, Unger C, Krönke M, Tumor nercrosis factor induces rapid production of 1,2 diaylglycerol by a phosphatidylcholine-specific phospholipase C. J Exp Med 174: 975-988, 1991.
34. Köhler L, Hass R, Wessel K, DeWitt DL, Kaever V, Resch K, Goppelt-Struebe M, Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U 937. Biochim Biophys Acta 1042: 395-403, 1990.
35. 3 and cell growth in monocytic U937 and Mono Mac 6 cells. Cell Biochem Funct 13: 19-23, 1995.
36. 2. Mol Pharmacol 48: 550-558, 1995.
37. 2 in pulmonary vascular smooth muscle cells. Cell Signal 7: 75-83, 1995.
38. 2 in fMet-Leu-Phe-challenged human polymorph neutrophils. Agents Actions Suppl 45: 297-301, 1995.
39. Clark S, Keogh R, Dunlop M, The role of protein kinase C in arachidonic acid release and prostaglandin E production from CHO cells transfected with EGF receptors. Biochim Biophys Acta 1224: 221-227, 1994.
40. Rao GN, Lassegue B, Alexander RW, Griendling KK, Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth muscle cells. Biochem J 299: 197-201, 1994.
41. 2 activation in collagen-stimulated human platelets. Biochem Med Metab Biol 51: 118-128, 1994.
42. 2. J Biol Chem 269: 19480-19487, 1994.
43. Schütze S, Machleidt T, Krönke M, The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction. J-Leukoc Biol 56: 533-541, 1994.
44. Fleer EAM, Unger C, Kim DJ, Eibl H, Metabolism of ether phospholipids and analogues in neoplastic cells. Lipids 22: 856-861, 1987.
45. 2 on bilayers containing lysophosphatidylcholine analogues and the effect of inhibitors. Biochem Pharmacol 33: 2541-2551, 1984.
46. Koehler KA, Hines J, Mansour EG, Rustum YM, Jahagirdar DV, Jain MK, Comparison of the membrane-related effects of cytarabine and other agents on model molecules. Biochem Pharmacol 34: 4025-4031, 1985.
47. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043-1051, 1991.
48. 2. J Biol Chem 266: 14850-14853, 1991.